Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Wholesaler Interest: Rates Make Forward Buys Pay; Do Generics Pay Better?

Executive Summary

AmerisourceBergen's renegotiated generic supply agreements give the wholesaler higher margins on multi-source products than it anticipated at the time of the merger

You may also be interested in...



Geneva Generic Augmentin Distribution Limited To Warehousing Drug Chains

Drug wholesalers, independent pharmacists and hospital group purchasing organizations are protesting Geneva Pharmaceuticals' decision to directly sell its generic version of GlaxoSmithKline's Augmentin (amoxicillin/clavulanate) only to drug store chains with their own warehouses

Geneva Generic Augmentin Distribution Limited To Warehousing Drug Chains

Drug wholesalers, independent pharmacists and hospital group purchasing organizations are protesting Geneva Pharmaceuticals' decision to directly sell its generic version of GlaxoSmithKline's Augmentin (amoxicillin/clavulanate) only to drug store chains with their own warehouses

Drug Wholesaler Forward Buying Continues; Supplier Behavior Is “Consistent”

Pharmaceutical wholesalers continue to find buy-side pricing opportunities despite the recent public scrutiny of manufacturer-reported trade inventory levels

Related Content

Latest News
See All
UsernamePublicRestriction

Register

PS039802

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel